Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...
Prior to assuming her current role at AstraZeneca, Sarin was CFO at Alexion. In December 2020, AstraZeneca acquired Alexion, ...
The U.S. government awarded Shionogi Inc. a contract worth up to $482 million to expand domestic manufacturing of Fetroja ...
Financially, the agreement includes a $20 million upfront payment to C4 Therapeutics, with the potential for additional ...
VESALIUS-CV data supported evolocumab reducing MACE in high-risk primary prevention diabetes over 4.8 years, reinforcing the ...
Pharmaceutical Executive: How does the complexity of obesity impact the effectiveness of GLP-1s? Mark Bagnall: This is one of ...
In today's Pharmaceutical Executive Daily, activist investor Shah Capital escalates its campaign against Novavax's board ...
Shah Capital plans “against” votes on directors and say-on-pay, while seeking to sway ISS and Glass Lewis rather than running ...
Air route diversions and constrained regional access are eroding schedule certainty for temperature-controlled air freight, ...
U.S. District Judge David Joseph, a Trump appointee sitting in Lafayette, Louisiana, refused Louisiana Attorney General Liz ...
Companion diagnostics (CDx), positioned at the intersection of pathology, drug development, and patient access, have emerged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results